Was Colorado’s House Speaker Crisanta Duran taking a page from California Assembly Speaker Anthony Rendon‘s book when she blocked introduction of the Health Care Cost Analysis Act of 2018?Read the letter about the status of the bill from Ivan J. Miller, Ph.D. and judge for […]
The Attorney General’s refusal signals his agreement with health consumer advocates, who argue that patients still are struggling to pay their bills, even when they have insurance. Advocates say it shows he understands there are still “unmet needs” for financial assistance for people who have high-deductible […]
The story of Korlym highlights how America’s drug development system can turn an old drug into a new one that treats relatively few — but often very desperate — patients. Sarah Jane Tribble, Kaiser Health News Even though the $550 yellow pills sold as Korlym have […]
Since 2013, the numbers of Americans supporting or opposing universal healthcare have gradually flipped themselves, and now polls over that time consistently show that a majority want universal healthcare. When will leaders listen? This most recent was a March Kaiser Family Foundation poll that asked […]
Pharmaceutical companies are using their savings from recent corporate tax cuts to buy back shares of their own stock, enriching executives and wealthy investors as prescription drug prices continue to skyrocket, says Robert Reich, former Secretary of Labor. “It’s a two part scam,” he said. […]
Research shows hospital consolidation has been driving prices higher and higher in recent years. And because more and more people have high-deductible insurance plans, they’re more likely to be on the hook for huge bills, like paying 33 times more for the same test. Alison Kodjak, […]
The time for political will and bold solutions trumping corporate greed in California is now. We must not let insurance companies and drug makers use their profits to intimidate our representatives, lower our expectations and allow this historic moment to slip away. Millions […]
In the bizarro profiteering world of the pharmaceutical industry, a 40-year-old cancer drug can increase in price by 1,400 percent in five years, and drug companies can spread the wealth around by funding new friends, with hundreds of millions of dollars finding their way to patient […]
